MIRUM PHARMACEUTICALS INCORPORATED (MIRM)

Mirion Technologies stock was slightly in the red by early afternoon on Wednesday, down about 1.7% near US$14.30 after a tough three months that left shares lower by more than 25%. The market reaction looks cautious, yet the headline from this earnings print is clear.

Mirion Technologies posted Q2 2026 revenue of $266.8M and net income attributable of $7.7M, with $77.4M in operating cash flow and $775.0M of convertible notes outstanding.

MIR Q2 Deep Dive: Margin Expansion and Nuclear Backlog Growth Offset Revenue Miss

Mirion Technologies reported second-quarter 2026 revenue of $266.8 million, up 19.7% year-over-year, with organic growth of 1% in line with expectations. Adjust

Although the revenue and EPS for Mirion Technologies (MIR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.